title: Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
abstract: BACKGROUND
  Increasing concern over long-term drug treatment of mild hypertension has stimulated several studies of weight reduction. Phase I of the Trial of Antihypertensive Interventions and Management demonstrated a short-term effect of weight loss on blood pressure control in overweight persons with mild hypertension, who were either taking placebo or taking low-dose monotherapy. Phase II investigates the long-term benefit of weight loss on the ability to maintain blood pressure control.
  
  
  METHODS
  From 10148 community-based screenees, 587 persons (5.8%), aged 21 to 65 years, entered a multicenter, randomized drug (double-blind, placebo-controlled) and diet trial. Participants had a diastolic blood pressure between 90 and 100 mm Hg and were at 110% to 160% of their ideal weight. They were randomized to a usual diet (n = 296) or to a weight loss diet (n = 291) and within each diet group to placebo, chlorthalidone, 25 mg/d, or atenolol, 50 mg/d. Treatment failure was defined as using additional antihypertensive medications if diastolic blood pressure rose above 90 mm Hg according to protocol-specified criteria.
  
  
  RESULTS
  At baseline, mean diastolic blood pressure was 93 mm Hg; systolic blood pressure, 143 mm Hg; weight, 88 kg; percent ideal weight, 137%; age, 48 years; 56% were men; and 33% were black. Mean follow-up was 4.5 years. There was a net loss of 2 to 3 kg with weight loss diet compared with usual diet over most of the follow-up period. The 5-year incidence of treatment failure was 56.7 per 100 participants with usual diet and 49.8 per 100 with weight loss. Long-term weight loss decreased failure of blood pressure control for those receiving placebo or low-dose diuretic or beta-blocker by 23%. The results were similar in direction in each drug group.
  
  
  CONCLUSIONS
  The Trial of Antihypertensive Interventions and Management demonstrated that weight reduction is an effective long-term therapy for maintaining blood pressure in the normal range when used as monotherapy or in combination with either thiazide diuretics or beta-blockers. Consequently, weight loss should be recommended for the management of obese individuals with mild hypertension.
authors.affiliation: Coordinating Center for Clinical Trials, University of Texas School of Public Health, Houston.
authors.forename: B R
authors.initials: BR
authors.lastname: Davis
authors.forename: M D
authors.initials: MD
authors.lastname: Blaufox
authors.forename: A
authors.initials: A
authors.lastname: Oberman
authors.forename: S
authors.initials: S
authors.lastname: Wassertheil-Smoller
authors.forename: N
authors.initials: N
authors.lastname: Zimbaldi
authors.forename: J A
authors.initials: JA
authors.lastname: Cutler
authors.forename: K
authors.initials: K
authors.lastname: Kirchner
authors.forename: H G
authors.initials: HG
authors.lastname: Langford
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001262:Atenolol / Q000008:administration & dosage; D002752:Chlorthalidone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000178:diet therapy*; D016016:Proportional Hazards Models; D016896:Treatment Outcome; D015431:Weight Loss / Q000502:physiology*
chemical_list: D000959:Antihypertensive Agents; D001262:Atenolol; D002752:Chlorthalidone